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ifferent cut-off used in this study. Various PocketMatch cut-offs that have been used in this study along with the justification and description has been mentioned here for each of the analysis carried out. Different network variants constructed in this study. The reference to the corresponding figures in the manuscript is also mentioned with the detailed description of the node and the edges in each of them. The purpose on such a network construction is also mentioned briefly.
Table S3
!"#$%&'$()*+$),-./ 0--12*34)42$)/ 5$6$%$(7$/8-9/ 1. Obtaining Structural Proteome
2. Deriving consensus binding site 22, 34, 35, 36, 37 and 38 3. Construction of Binding site similarity network
4. Deriving drug binding sites
5. Validation (Predicting pocket, Ligand association, Clustering, drug association) 47, 51, 42, 50, 48 6. Extracting sets/groups of similar binding sites from binding Site similarity network (nodes as binding sites and edges with similarity relationship PMAX >= 0.7)
•! MCODE 39
7. Construction of binding-site similarity network at PMAX !0.6 and obtaining CC for each node in the network
7. Clustering of bipartite network (with two types of nodes predicted Mtb pockets of target proteins and approved drug binding sites, edges being the binding site similarity >=0.7)
•! TNET 60
Datasets and tools used in the study. Various datasets and tools used in this study has been explained with the brief description of the experiment/method and the corresponding reference number in the manuscript. 
Supplementary Text 2
Kinnings et.al. had proposed TB-drugome to understand the interactions of Mtb proteins with the currently approved drugs by constructing a drug-target network through similarities at the binding site. In their study, SMAP was used to obtain the similarity between predicted pockets in Mtb structural proteome and the drug-binding sites of the approved drugs. A systematic comparison was carried out at two levels -firstly the prediction of pockets, followed by the drug association obtained through binding site similarity.
The pockets were extracted from the ehits docking poses obtained from the TBdrugome studies. All the 1097 predicted pockets from the MODBASE models reported from TBdrugome studies were compared to pockets predicted from our approach. Overlap of atleast one residue was considered for the pockets detected by both the methods. Out of 1097 cases, 662 pockets detected had an overlap of atleast one residue, thus covering 60% of the pockets reported already. PocketMatch was also run to check all the drug associations reported by TBdrugome study and an average PMAX score of 0.40 was obtained. Data can be accessed at http://proline.biochem.iisc.ernet.in/mtbpocketome/methods.phpunder 'Comparison to TB-Drugome' section. 
